The Roots Analysis team is putting in its best effort to offer our clients / readers a reliable source of information, regarding how the pharmaceutical and biotech sectors are coping in the midst of the COVID-19 pandemic. Our intention is to generate realistic insights, based on a variety of factors, which are anticipated to influence both prevalent and future market dynamics. Reach out to us for any help.

Patient Recruitment and Retention Services Market, 2019-2030 [COVID-19 SERIES]

  • Lowest Price Guaranteed From USD 4,499

  • Published
    February 2019

  • Pages
    303

  • View Count
    9122

Example Insights

 

Overview

Due to several factors, such as steady rise in global clinical trials, demand for highly specific study participants, and complex inclusion-exclusion criteria, and the challenges associated with enrolling patients in modern clinical trials, pharmaceutical companies are increasingly using the services of dedicated patient recruitment firms.

-- Chief Operations Officer, Israel-based Small-sized Patient Recruitment Firm

[COVID-19 SERIES] Clinical trials represent an arduous step in the drug development process and are crucial to understanding the safety and efficacy profiles of novel therapeutic interventions. As these trials are prone to delays, and can even fail altogether, they impose an immense financial pressure on sponsors. Amongst several known challenges, patient recruitment is considered to be one of the rate limiting steps when it comes to getting drugs to the market. It is estimated that 80% of clinical trials do not meet their designated patient enrolment deadlines. In fact, around 37% of research sites fail to meet their subject accrual goals, while more than 10% don’t even enroll a single patient. In addition, retaining patients is also a matter of concern, considering that the approximate dropout rate across clinical studies is around 30%. Delays in product launch, due to inability of the sponsors to recruit / retain patients, are highly common and are estimated to result in an average loss of USD 8 million per day in opportunity costs, for a blockbuster drug.

The abovementioned challenges have led several players in the pharmaceutical industry to outsource their patient recruitment-related needs to capable, specialty service providers. Employing contract service providers has been shown to expedite the patient recruitment process. Such service providers employ a variety of outreach methods, such as social media, mobile technologies, electronic health records (EHRs) and real-world evidence (RWE), and, over time, have attained a vital role in the successful conduct of clinical research. Although some big pharma players carry out patient recruitment in-house, the growing complexity of clinical trials and demand for niche patient populations for studies evaluating orphan drugs / personalized medicines is likely to prompt more developer companies to outsource various aspects of their clinical research-related operations in the foreseen future. In fact, the market has recently witnessed the establishment of several partnerships, which include agreements between study sponsors and patient recruitment firms (outsourcing deals) and partnerships between stakeholders aimed to combine their respective services portfolios related to patient recruitment and retention (service alliances). This niche services industry has also witnessed some consolidation as multiple smaller players have been acquired by more established entities, in an effort to expand geographical reach.

 

Scope of the Report

The Patient Recruitment and Retention Services, 2019-2030 report offers a comprehensive study of the current scenario and future potential of the players providing patient enrollment and retention services. The study features an in-depth analysis, highlighting the capabilities of the various stakeholders in this domain. In addition to other elements, the study includes:

  • A detailed assessment of the current market landscape of companies offering patient recruitment and retention services, including information on over 10 types of patient outreach methods employed, types of services offered ([A] patient recruitment (including pre-screening and Institutional Review Board (IRB) / Ethics Committee (EC) submission), [B] patient retention (considering various strategies, such as the use of study-branded gifts, study-branded reminders, providing education and support materials, reimbursement programs, transportation programs, patient engagement web site, patient reconnect programs, mobile applications to track patient engagement and others) and [C] other associated services (including site identification and selection,study feasibility / protocol development, project management, clinical trial monitoring and other services), year of establishment, geographical location, and size of company. The chapter also covers an analysis of the geographical reach and therapeutic expertise of service providers, along with details on the payment model, patient recruitment platforms / technologies used, and the various certifications / accreditations awarded by regulatory bodies.
  • An analysis of the most active regions (in terms of patient recruitment activity), based on the locations of headquarters of companies engaged in this domain, featuring schematic world map representations that highlight key hubs across the globe.
  • An insightful 2X2 representation of the results of a competitiveness analysis of various service providers (segregated into three peer groups based on their employee count (small-sized (1-50 employees), mid-sized (50-200 employees) and large (>200 employees)), highlighting capable players in this domain, based on their respective capabilities.
  • Comprehensive profiles of patient recruitment and retention service providers, featuring information on the location of their headquarters, year of establishment, patient recruitment services / platforms portfolio, recent developments and a comprehensive future outlook.
  • An analysis of the partnerships that have been established in the recent past, covering outsourcing agreements, service alliances, acquisitions, joint ventures, mergers, technology licensing and development agreements, and other forms of partnerships.
  • A review of emerging trends in the industry, including the use of social media, mobile technologies, EHRs and RWE, to overcome the challenges associated with patient recruitment and retention.

One of the key objectives of the report was to estimate the existing market size and review the potential growth opportunities for patient recruitment service providers over the coming decade. Based on several parameters, we have provided an informed estimate of the likely evolution of this market in the short to mid-term and long term, for the period 2019-2030. In addition, we have segmented the future opportunity across [A] therapeutic area (oncology, infectious diseases, cardiovascular diseases, CNS disorders, respiratory disorders, metabolic disorders, and others), [B] steps in patient recruitment process (pre-screening and screening), [C] phases of development (phase I, phase II, phase III and phase IV), and [D] different global regions (North America, Europe, Asia-Pacific and rest of the world). In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios portraying the conservative, base and optimistic tracks of the industry’s evolution.

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals (in alphabetical order of company names):

  • Simon Klaasen (Co-founder and Managing Director, Link2Trials)
  • Hagit Nof (Chief Operation Officer and Business Development, nRollmed)
  • Paul Ivsin (Managing Director, Seeker Health)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Contents

Chapter Outlines

Chapter 2 is an executive summary of the insights captured in our research. It offers a high-level view on the current state of the patient recruitment and retention services market and describes the upcoming opportunity in short to mid-term and long term.

Chapter 3 provides a general introduction to the patient recruitment and retention process in clinical trials. It includes a detailed discussion on the different phases of clinical trials, patient recruitment and its associated challenges, various strategies used to enhance patient accrual, affiliated ethical considerations and outsourcing activity in this domain. Further, it includes a detailed discussion on the various patient recruitment services offered by different contract service providers. Additionally, the chapter features a discussion on diverse patient retention strategies that are presently being employed to prevent enrolled participants from dropping out of clinical research studies.

Chapter 4 provides a comprehensive overview of the various types of patient outreach methods used by contract service providers in this domain, to identify and enroll patients in clinical trials. The chapter also highlights the various advantages and limitations of these outreach methods.

Chapter 5 provides a comprehensive view of the current market landscape of companies that offer patient recruitment and retention services. It presents detailed analyses on the basis of their year of establishment, geographical location, size of company, type of services offered, type of patient outreach methods, geographical reach, and the therapeutic expertise of service providers. In addition, it includes details on the payment model, patient recruitment platforms / technologies used, and the various certifications / accreditations awarded to companies, by regulatory bodies from across the world.

Chapter 6 features a competitiveness analysis of the companies providing patient recruitment and retention services based on various parameters, such as patient outreach methods, number of patient recruitment and retention services offered, therapeutic expertise, geographical reach and year of establishment. In the chapter, stakeholder entities have been plotted on a 2X2 matrix, having a company’s Experience (based on its year of establishment)(abscissa) and Company Competitiveness (ordinate) as the two axes.

Chapter 7 features detailed profiles of key stakeholders in this industry; each profile provides information on their headquarters, year of establishment, patient recruitment services / platforms portfolio, recent developments and a comprehensive future outlook.

Chapter 8 features an elaborate discussion and analysis of the various partnerships / collaborations that have been inked amongst players in this market. It includes a brief description on the various types of partnership models (outsourcing agreements, service alliances, acquisitions, joint ventures, mergers, technology licensing agreements, development agreements, and others) adopted by industry stakeholders, highlighting the most common forms of deals / agreements that have been established in the period between 2013-2018.

Chapter 9 provides a detailed overview of the prevalent trends in the patient recruitment and retention services domain, including the use of social media, mobile technologies, EHRs and RWE, to overcome the challenges associated with patient recruitment and retention in clinical research.

Chapter 10 features a detailed discussion on the upcoming opportunities (such as rise in the number of clinical trials, development of personalized medicine / orphan drugs, growing opportunities in emerging markets, increasing preference for one-stop solutions and others) in the field of patient recruitment and retention that are likely to impact the evolution of the market over the coming years.

Chapter 11 features a comprehensive market forecast analysis, highlighting the future potential of patient recruitment services market till the year 2030. We have segmented the projected opportunity on the basis of [A] therapeutic area (oncology, infectious diseases, cardiovascular diseases, CNS disorders, respiratory disorders, metabolic disorders, and others), [B] steps in patient recruitment process (pre-screening and screening), [C] phases of development (phase I, phase II, phase III and phase IV), and [D] different global regions (North America, Europe, Asia-Pacific and rest of the world).

Chapter 12 summarizes the entire report. It presents a list of key takeaways from the report, and offers our independent opinion on the current market scenario.

Chapter 13 is a collection of interview transcripts of the discussions that were held with key stakeholders in this market. The chapter provides details of interviews held with Simon Klaasen (Co-founder and Managing Director, Link2Trials), Hagit Nof (Chief Operation Officer and Business Development, nRollmed) and Paul Ivsin (Managing Director, Seeker Health).

Chapter 14 is an appendix, which provides tabulated data and numbers for all the figures included in the report.

Chapter 15 is an appendix, which provides the list of companies and organizations mentioned in the report. 

 

Table of Contents

1. PREFACE 
1.1. Scope of the Report 
1.2. Research Methodology
1.3. Chapter Outlines 
   
2. EXECUTIVE SUMMARY
   
3. PATIENT RECRUITMENT AND RETENTION IN CLINICAL TRIALS
3.1. Chapter Overview 
3.2. Clinical Trials 
3.2.1. Clinical Trial Phases 
   
3.3. Patient Recruitment 
3.3.1. The Patient Recruitment Process
3.3.2. Challenges Associated with Patient Recruitment
3.3.3. Strategies to Improve Patient Recruitment
3.3.4. Ethical Considerations
   
3.4. Outsourcing of Patient Recruitment
3.4.1. Patient Recruitment Services
   
3.5. Patient Retention 
3.5.1. Patient Retention Services
   
4. PATIENT OUTREACH METHODS
4.1. Chapter Overview 
4.2. Patient Outreach Methods
   
4.2.1. Traditional Media 
4.2.1.1. Physician Referrals 
4.2.1.2. Television 
4.2.1.3. Radio  
4.2.1.4. Print Media (Newspaper, Flyers, Brochures and Posters)
4.2.1.5. Direct Mail Campaigns
4.2.1.6. Cold Call / Call Center
4.2.1.7. Advantages and Limitations of Traditional Media
   
4.2.2. Emerging / Novel Methods
4.2.2.1. Social Media 
4.2.2.1.1. Social Media Platforms Used in Patient Recruitment
4.2.2.1.1.1. Geo-Social Media 
4.2.2.1.1.2. Social Networking Websites
4.2.2.1.2. Advantages and Limitations of Social Media
   
4.2.2.2. Mobile / Software Applications
4.2.2.3. Patient Networks 
4.2.2.4. Patient Advocacy Groups
4.2.2.5. Electronic Medical Records (EMRs) / Electronic Health Records (EHRs) and Other Health Data
4.2.2.6. Promotion of Trials in Indication Specific Events for Patients
   
4.2.3. Best Practices / Recommendations for Patient Outreach
   
5. COMPETITIVE MARKET LANDSCAPE OF PATIENT RECRUITMENT AND RETENTION SERVICE PROVIDERS
5.1. Chapter Overview 
5.2. Patient Recruitment and Retention Service Providers: Overall Market Landscape
5.2.1. Analysis by Year of Establishment 
5.2.2. Analysis by Company Size
5.2.3. Analysis by Geography
5.2.4. Analysis by Patient Recruitment and Retention Services Offered
5.2.5. Analysis by Patient Outreach Methods
5.2.6. Analysis by Patient Recruitment Associated Services
5.2.7. Analysis by Patient Retention Methods
5.2.8. Analysis by Geographical Reach
5.2.9. Analysis by Therapeutic Expertise
5.2.10. Information on Payment Model, Recruitment Technology / Platform, and Regulatory Approval / Certification / Compliance Status
   
6. COMPANY COMPETITIVENESS ANALYSIS
6.1. Chapter Overview 
6.2. Methodology 
6.3. Assumptions and Key Parameters
6.4. Patient Recruitment and Retention Service Providers: Company Competitiveness Analysis
6.4.1. Small-Sized Companies
6.4.2. Mid-Sized Companies
6.4.3. Large Companies 
   
7. COMPANY PROFILES
7.1. Chapter Overview 
7.2. Patient Recruitment Service Providers in North America
7.2.1. Acurian  
7.2.1.1. Company Overview 
7.2.1.2. Financial Information
7.2.1.3. Patient Recruitment and Retention Services
7.2.1.4. Recent Developments
7.2.1.5. Future Outlook 
   
7.2.2. BBK Worldwide 
7.2.2.1. Company Overview 
7.2.2.2. Financial Information
7.2.2.3. Patient Recruitment and Retention Services
7.2.2.4. Recent Developments
7.2.2.5. Future Outlook 
   
7.2.3. Bright Pharmaceuticals Services
7.2.3.1. Company Overview 
7.2.3.2. Patient Recruitment and Retention Services
7.2.3.3. Future Outlook 
   
7.2.4. ClinEdge  
7.2.4.1. Company Overview 
7.2.4.2. Patient Recruitment and Retention Services
7.2.4.3. Recent Developments
7.2.4.4. Future Outlook 
   
7.2.5. CSSi  
7.2.5.1. Company Overview 
7.2.5.2. Patient Recruitment and Retention Services
7.2.5.3. Recent Developments
7.2.5.4. Future Outlook 
   
7.2.6. CTM  
7.2.6.1. Company Overview 
7.2.6.2. Patient Recruitment and Retention Services
7.2.6.2 Future Outlook 
   
7.2.7. Integrated Clinical Trial Services (ICTS)
7.2.7.1. Company Overview 
7.2.7.2. Patient Recruitment and Retention Services
7.2.7.3. Recent Developments
7.2.7.4. Future Outlook 
   
7.2.8. MMG  
7.2.8.1. Company Overview 
7.2.8.2. Patient Recruitment and Retention Services
7.2.8.3. Future Outlook 
   
7.2.9. Topstone Research 
7.2.9.1. Company Overview 
7.2.9.2. Patient Recruitment and Retention Services
7.2.9.3. Future Outlook 
   
7.2.10. WCCT Global 
7.2.10.1. Company Overview 
7.2.10.2. Financial Information
7.2.10.3. Patient Recruitment Services
7.2.10.4. Recent Developments
7.2.10.5. Future Outlook 
   
7.3. Patient Recruitment Service Providers in Europe
7.3.1. Antidote  
7.3.1.1. Company Overview 
7.3.1.2. Financial Information
7.3.1.3. Patient Recruitment and Retention Services
7.3.1.4. Recent Developments
7.3.1.5. Future Outlook 
   
7.3.2. FIDELIS RESEARCH
7.3.2.1. Company Overview 
7.3.2.2. Financial Information
7.3.2.3. Patient Recruitment and Retention Services
7.3.2.4. Recent Developments
7.3.2.5. Future Outlook 
   
7.3.3. Ignite Data 
7.3.3.1. Company Overview 
7.3.3.2. Financial Information
7.3.3.3. Patient Recruitment and Retention Services
7.3.3.4. Future Outlook 
   
7.3.4. Polaris BioPharma Consulting
7.3.4.1. Company Overview 
7.3.4.2. Patient Recruitment and Retention Services
7.3.4.3. Recent Developments
   
7.3.5. Tudor Reilly Health 
7.3.5.1. Company Overview 
7.3.5.2. Financial Information
7.3.5.3. Patient Recruitment and Retention Services
7.3.5.4. Recent Developments
7.3.5.5. Future Outlook 
   
7.4. Patient Recruitment Services Providers in Asia Pacific
7.4.1. CROèe  
7.4.1.1. Company Overview 
7.4.1.2. Patient Recruitment and Retention Services
7.4.1.3. Recent Developments
7.4.1.4. Future Outlook 
   
7.4.2. Jsure Healthmedia 
7.4.2.1. Company Overview 
7.4.2.2. Patient Recruitment and Retention Services
7.4.2.3. Future Outlook 
   
7.4.3. TrialWire  
7.4.3.1. Company Overview 
7.4.3.2. Patient Recruitment and Retention Services
7.4.3.3. Recent Developments
   
7.4.4. Pacific Groove 
7.4.4.1. Company Overview 
7.4.4.2. Patient Recruitment and Retention Services
7.4.4.3. Recent Developments
7.4.4.4. Future Outlook 
   
8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview 
8.2. Partnership Models 
   
8.3. Patient Recruitment and Retention Services: List of Partnerships and Collaborations
8.3.1. Analysis by Year of Partnerships
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Purpose of Agreement
8.3.4. Analysis by Therapeutic Area
8.3.5. Most Active Players: Analysis by Number of Partnerships
8.3.6. Geographical Analysis
8.3.6.1. Intercontinental and Intracontinental Agreements
   
9. RECENT TRENDS IN PATIENT RECRUITMENT AND RETENTION
9.1. Chapter Overview 
9.1.1. Social Media-based Campaigning to Accelerate Patient Recruitment in Clinical Trials
9.1.2. Adoption of Mobile Technologies for Patient Recruitment and Retention
9.1.3. Use of EHR Data to Improve Patient Recruitment Rates
9.1.4. Other Real World Data Sources to Help Overcome Patient Recruitment-Related Challenges
9.1.5. Growing Focus on Conducting Clinical Research in Emerging Markets
   
10. FUTURE GROWTH OPPORTUNITIES 
10.1. Chapter Overview 
10.1.1. Anticipated Increase in the Number of Global Clinical Trials
10.1.2. Growing Demand for Orphan Drugs and Personalized Medicine
10.1.3. Increased Offshoring of Clinical Development Operations to Emerging Regions
10.1.4. Availability of Service Providers Offering One-Stop-Solutions
10.1.5. Stringent Regulations and Complex Study Protocols Expected to Promote Outsourcing
   
11. MARKET SIZING AND OPPORTUNITY ANALYSIS
11.1. Chapter Overview 
11.2. Forecast Methodology and Key Assumptions
11.3. Overall Patient Recruitment Services Market, 2019-2030
11.4. Patient Recruitment Services Market: Distribution by Therapeutic Area, 2019-2030
11.5. Patient Recruitment Services Market: Distribution by Steps in Patient Recruitment Process, 2019-2030
11.6. Patient Recruitment Services Market: Distribution by Phase of Development, 2019-2030
11.7. Patient Recruitment Services Market: Distribution by Geography, 2019-2030
11.7.1. Patient Recruitment Services Market: Market Attractiveness Analysis by Country, 2019-2030
11.7.2. Patient Recruitment Services Market in North America, 2019-2030
11.7.2.1. Patient Recruitment Services Market in the US: Distribution by Phase of Development, 2019-2030
11.7.2.2. Patient Recruitment Services Market in the US: Distribution by Therapeutic Area, 2019-2030
11.7.2.3. Patient Recruitment Services Market in Canada: Distribution by Phase of Development, 2019-2030
11.7.2.4. Patient Recruitment Services Market in Canada: Distribution by Therapeutic Area, 2019-2030
   
11.7.3. Patient Recruitment Services Market in EU5, 2019-2030
11.7.3.1. Patient Recruitment Services Market in Germany: Distribution by Phase of Development, 2019-2030
11.7.3.2. Patient Recruitment Services Market in Germany: Distribution by Therapeutic Area, 2019-2030
11.7.3.3. Patient Recruitment Services Market in France: Distribution by Phase of Development, 2019-2030
11.7.3.4. Patient Recruitment Services Market in France: Distribution by Therapeutic Area, 2019-2030
11.7.3.5. Patient Recruitment Services Market in the UK: Distribution by Phase of Development, 2019-2030
11.7.3.6. Patient Recruitment Services Market in the UK: Distribution by Therapeutic Area, 2019-2030
11.7.3.7. Patient Recruitment Services Market in Italy: Distribution by Phase of Development, 2019-2030
11.7.3.8. Patient Recruitment Services Market in Italy: Distribution by Therapeutic Area, 2019-2030
11.7.3.9. Patient Recruitment Services Market in Spain: Distribution by Phase of Development, 2019-2030
11.7.3.10. Patient Recruitment Services Market in Spain: Distribution by Therapeutic Area, 2019-2030
   
11.7.4. Patient Recruitment Services Market in Asia Pacific, 2019-2030
11.7.4.1. Patient Recruitment Services Market in Japan: Distribution by Phase of Development, 2019-2030
11.7.4.2. Patient Recruitment Services Market in Japan: Distribution by Therapeutic Area, 2019-2030
11.7.4.3. Patient Recruitment Services Market in South Korea: Distribution by Phase of Development, 2019-2030
11.7.4.4. Patient Recruitment Services Market in South Korea: Distribution by Therapeutic Area, 2019-2030
11.7.4.5. Patient Recruitment Services Market in Australia: Distribution by Phase of Development, 2019-2030
11.7.4.6. Patient Recruitment Services Market in Australia: Distribution by Therapeutic Area, 2019-2030
11.7.4.7. Patient Recruitment Services Market in China: Distribution by Phase of Development, 2019-2030
11.7.4.8. Patient Recruitment Services Market in China: Distribution by Therapeutic Area, 2019-2030
11.7.4.9. Patient Recruitment Services Market in India: Distribution by Phase of Development, 2019-2030
11.7.4.10. Patient Recruitment Services Market in India: Distribution by Therapeutic Area, 2019-2030
11.7.5. Patient Recruitment Services Market in Rest of the World, 2019-2030
11.7.5.1. Patient Recruitment Services Market in Rest of the World: Distribution by Phase of Development, 2019-2030
11.7.5.2. Patient Recruitment Services Market in Rest of the World: Distribution by Therapeutic Area, 2019-2030
   
12. CONCLUSION 
12.1. Evolving Requirements Related to Patient Enrolment have Imposed a Significant Burden on Drug Developers, Causing Many to Outsource their Recruitment and Retention-related Processes
12.2. Several CROs Offer Patient Recruitment and Retention Services across the Globe; North America and Europe have Emerged as Key Hubs
12.3. Currently, a Variety of Outreach Methods are being used to Enroll Patient from Across Different Geographies and Therapeutic Areas
12.4. Innovation, Use of Real World Evidence and the Establishment of Strategic Alliances between Stakeholders are Anticipated to Act as Key Market Enablers
12.5. Driven by the Increasing Demand for Niche and Highly Specific Patient Populations in Clinical Trials, the Patient Recruitment Services Market is Anticipated to Witness Significant Growth in the Coming Decade
   
13. INTERVIEW TRANSCRIPTS  
13.1. Chapter Overview    
13.2. Link2Trials 
13.2.1. Interview Transcript: Simon Klaasen, Co-founder and Managing Director

13.3. nRollmed  
13.3.1. Interview Transcript: Hagit Nof, Chief Operation Officer and Business Development Officer

13.4. Seeker Health 
13.4.1. Interview Transcript: Paul Ivsin, Managing Director
   
14. APPENDIX 1: TABULATED DATA
   
15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

 

List of Figures

Figure 3.1 Factors Contributing to Clinical Trial Costs
Figure 3.2 The Patient Recruitment Process
Figure 3.3 Factors Influencing Participation in Clinical Trials
Figure 3.4 Reasons for Patient Dropouts from Clinical Studies
Figure 4.1 Patient Recruitment: Advantages and Limitations of Traditional Media
Figure 4.2 Patient Recruitment: Advantages and Limitations of Social Media
Figure 5.1 Patient Recruitment and Retention Service Providers: Distribution by Year of Establishment           
Figure 5.2 Patient Recruitment and Retention Service Providers: Distribution by Company Size        
Figure 5.3 Patient Recruitment and Retention Service Providers: Distribution by Geography 
Figure 5.4 Patient Recruitment and Retention Service Providers: Distribution by Geography and Company Size
Figure 5.5 Patient Recruitment and Retention Service Providers: Distribution by Type of Services Offered
Figure 5.6 Patient Recruitment and Retention Service Providers: Distribution by Type of Patient Outreach Methods         
Figure 5.7 Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Outreach Methods Offered
Figure 5.8 Patient Recruitment and Retention Service Providers: Distribution by Patient Recruitment Associated Services  
Figure 5.9 Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Recruitment Associated Services Offered     
Figure 5.10 Patient Recruitment and Retention Service Providers: Distribution by Patient Retention Methods         
Figure 5.11 Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Retention Methods     
Figure 5.12 Patient Recruitment and Retention Service Providers: Distribution by Geographical Reach           
Figure 5.13 Patient Recruitment and Retention Service Providers: Distribution by Therapeutic Expertise           
Figure 6.1 Company Competitiveness Analysis: Small-Sized Players
Figure 6.2 Company Competitiveness Analysis: Mid-Sized Players
Figure 6.3 Company Competitiveness Analysis: Large Players
Figure 7.1 Acurian: Innovative Tools / Approaches for Patient Recruitment
Figure 7.2 Acurian: Patient Recruitment Solutions and Strategies
Figure 7.3 BBK Worldwide: Service Portfolio
Figure 7.4 Bright Pharmaceutical Services: Service Portfolio
Figure 7.5 ClinEdge: Service Portfolio
Figure 7.6 CSSi: Patient Recruitment and Retention Capabilities
Figure 7.7 CSSi: Patient Recruitment Strategies
Figure 7.8 CTM: Patient Recruitment Process
Figure 7.9 CTM: Outreach Methods Used to Recruit Patients
Figure 7.10 CTM: Technologies Used to Recruit Patients
Figure 7.11 Topstone Research: Service Portfolio
Figure 7.12 Antidote: Services Portfolio
Figure 7.13 Antidote Base: Patient Recruitment Process
Figure 7.14 Fidelis Research: Service Portfolio
Figure 7.15 Ignite Data: Patient Recruitment and Call-Screening Process
Figure 7.16 Ignite Data: Patient Recruitment and Retention Strategies
Figure 7.17 Ignite Data: Real-World Data Delivery Process
Figure 7.18 Polaris Biopharma Consulting: Core Capabilities
Figure 7.19 Polaris Biopharma Consulting: Service Portfolio
Figure 7.20 Tudor Reilly Health: Service Portfolio
Figure 7.21 Tudor Reilly Health: Local Support Divisions
Figure 7.22 CROèe: Service Portfolio
Figure 7.23 TrialWire: Patient Recruitment Process
Figure 7.24 TrialWire: The RapidRecruit Platform
Figure 7.25 Pacific Groove: Business Divisions
Figure 7.26 Pacific Groove: Patient Enrollment Process
Figure 8.1 Partnerships and Collaborations: Distribution by Year, 2013-2018
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Purpose of Agreement
Figure 8.4 Partnerships and Collaborations: Analysis by Therapeutic Area
Figure 8.5 Partnerships and Collaborations: Most Active Players
Figure 8.6 Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
Figure 9.1 Recent Trends in Patient Recruitment and Retention
Figure 10.1 Patient Recruitment Services Market: Future Growth Opportunities
Figure 10.2 Number of Global Clinical Trials Registered by Year, 2000-2018
Figure 10.3 Evolution of Clinical Trial Regulations in the US
Figure 11.1 Overall Patient Recruitment Services Market, 2019-2030 (USD Billion)
Figure 11.2 Patient Recruitment Services Market: Distribution by Therapeutic Area, 2019 and 2030 (%)  
Figure 11.3 Patient Recruitment Services Market: Distribution by Steps in Patient Recruitment Process, 2019-2030 (USD Billion)
Figure 11.4 Patient Recruitment Services Market: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.5 Patient Recruitment Services Market: Distribution by Geography, 2019-2030 (USD Billion)
Figure 11.6 Patient Recruitment Services Market: Market Attractiveness Analysis by Country
Figure 11.7 Patient Recruitment Services Market in North America, 2019-2030 (USD Billion)
Figure 11.8 Patient Recruitment Services Market in the US: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.9 Patient Recruitment Services Market in the US: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.10 Patient Recruitment Services Market in Canada: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.11 Patient Recruitment Services Market in Canada: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.12 Patient Recruitment Services Market in EU5, 2019-2030 (USD Billion)
Figure 11.13 Patient Recruitment Services Market in Germany: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.14 Patient Recruitment Services Market in Germany: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.15 Patient Recruitment Services Market in France: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.16 Patient Recruitment Services Market in France: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.17 Patient Recruitment Services Market in the UK: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.18 Patient Recruitment Services Market in the UK: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.19 Patient Recruitment Services Market in Italy: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.20 Patient Recruitment Services Market in Italy: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.21 Patient Recruitment Services Market in Spain: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.22 Patient Recruitment Services Market in Spain: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.23 Patient Recruitment Services Market in Asia Pacific, 2019-2030 (USD Billion)
Figure 11.24 Patient Recruitment Services Market in Japan: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.25 Patient Recruitment Services Market in Japan: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.26 Patient Recruitment Services Market in South Korea: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.27 Patient Recruitment Services Market in South Korea: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.28 Patient Recruitment Services Market in Australia: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.29 Patient Recruitment Services Market in Australia: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.30 Patient Recruitment Services Market in China: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.31 Patient Recruitment Services Market in China: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.32 Patient Recruitment Services Market in India: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.33 Patient Recruitment Services Market in India: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 11.34 Patient Recruitment Services Market in Rest of the World, 2019-2030 (USD Billion)
Figure 11.35 Patient Recruitment Services Market in Rest of the World: Distribution by Phase of Development, 2019-2030 (USD Billion)
Figure 11.36 Patient Recruitment Services Market in Rest of the World: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Figure 12.1 Patient Recruitment and Retention Market: 2019 and 2030 (USD Billion)

 

List of Tables

Table 3.1 Salient Features of Clinical Trial Phases
Table 4.1 Traditional and Emerging Patient Outreach Methods
Table 5.1 List of Patient Recruitment and Retention Service Providers 
Table 5.2 Patient Recruitment and Retention Service Providers: Information on Patient Outreach Methods 
Table 5.3 Patient Recruitment and Retention Service Providers: Information on Type of Patient Recruitment Services
Table 5.4 Patient Recruitment and Retention Service Providers: Information on Patient Retention Methods
Table 5.5 Patient Recruitment and Retention Service Providers: Information on Geographical Reach
Table 5.6 Patient Recruitment and Retention Service Providers: Information on Therapeutic Expertise
Table 5.7 Patient Recruitment and Retention Service Providers: Information on Payment Model, Recruitment Technology / Platform, and Regulatory Approval / Certification / Compliance Status
Table 7.1 Acurian: Funding
Table 7.2 Acurian: Future Outlook
Table 7.3 BBK Worldwide: Future Outlook
Table 7.4 ClinEdge: Future Outlook
Table 7.5 CSSi: Future Outlook
Table 7.6 WCCT Global: Future Outlook
Table 7.7 Antidote: Funding
Table 7.8 Antidote: Future Outlook
Table 7.9 Ignite Data: Future Outlook
Table 7.10 Tudor Reilly Health: Future Outlook
Table 7.11 CROèe: Future Outlook
Table 7.12 Pacific Groove: Future Outlook
Table 8.1 Patient Recruitment and Retention Services: Partnerships and Collaborations, 2013-2018
Table 14.1 Patient Recruitment and Retention Service Providers: Distribution by Year of Establishment    
Table 14.2 Patient Recruitment and Retention Service Providers: Distribution by Company Size    
Table 14.3 Patient Recruitment and Retention Service Providers: Distribution by Geography    
Table 14.4 Patient Recruitment and Retention Service Providers: Distribution by Geography and Company Size    
Table 14.5 Patient Recruitment and Retention Service Providers: Distribution by Type of Services Offered
Table 14.6 Patient Recruitment and Retention Service Providers: Distribution by Type of Patient Outreach Methods    
Table 14.7 Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Outreach Methods Offered
Table 14.8 Patient Recruitment and Retention Service Providers: Distribution by Patient Recruitment Associated Services    
Table 14.9 Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Recruitment Associated Services Offered    
Table 14.10 Patient Recruitment and Retention Service Providers: Distribution by Patient Retention Methods    
Table 14.11 Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Retention Methods     
Table 14.12 Patient Recruitment and Retention Service Providers: Distribution by Geographical Reach    
Table 14.13 Patient Recruitment and Retention Service Providers: Distribution by Therapeutic Expertise    
Table 14.14 Company Competitiveness Analysis: Small-Sized Players
Table 14.15 Company Competitiveness Analysis: Mid-Sized Players
Table 14.16 Company Competitiveness Analysis: Large Players
Table 14.17 Overall Patient Recruitment Services Market, 2019-2030 (USD Billion)
Table 14.18 Patient Recruitment Services Market: Distribution by Therapeutic Area, 2019 and 2030 (%)
Table 14.19 Patient Recruitment Services Market: Distribution by Steps in Patient Recruitment Process, 2019-2030 (USD Billion)
Table 14.20 Patient Recruitment Services Market: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.21 Patient Recruitment Services Market: Distribution by Geography, 2019-2030 (USD Billion)
Table 14.22 Patient Recruitment Services Market: Market Attractiveness Analysis by Country
Table 14.23 Patient Recruitment Services Market in North America, 2019-2030 (USD Billion)
Table 14.24 Patient Recruitment Services Market in the US: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.25 Patient Recruitment Services Market in the US: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.26 Patient Recruitment Services Market in Canada: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.27 Patient Recruitment Services Market in Canada: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.28 Patient Recruitment Services Market in EU5, 2019-2030 (USD Billion)
Table 14.29 Patient Recruitment Services Market in Germany: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.30 Patient Recruitment Services Market in Germany: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.31 Patient Recruitment Services Market in France: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.32 Patient Recruitment Services Market in France: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.33 Patient Recruitment Services Market in the UK: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.34 Patient Recruitment Services Market in the UK: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.35 Patient Recruitment Services Market in Italy: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.36 Patient Recruitment Services Market in Italy: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.37 Patient Recruitment Services Market in Spain: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.38 Patient Recruitment Services Market in Spain: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.39 Patient Recruitment Services Market in Asia Pacific, 2019-2030 (USD Billion)
Table 14.40 Patient Recruitment Services Market in Japan: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.41 Patient Recruitment Services Market in Japan: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.42 Patient Recruitment Services Market in South Korea: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.43 Patient Recruitment Services Market in South Korea: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.44 Patient Recruitment Services Market in Australia: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.45 Patient Recruitment Services Market in Australia: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.46 Patient Recruitment Services Market in China: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.47 Patient Recruitment Services Market in China: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.48 Patient Recruitment Services Market in India: Distribution by Phase of Development, 2019-2030 (USD Billion)
Table 14.49 Patient Recruitment Services Market in India: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.50 Patient Recruitment Services Market in Rest of the World, 2019-2030 (USD Billion)
Table 14.51 Phases of Development, 2019-2030 (USD Billion)
Table 14.52 Patient Recruitment Services Market in Rest of the World: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
Table 14.53 Patient Recruitment and Retention Market: 2019 and 2030 (USD Billion)

 

List of Companies

The following companies / institutes / government bodies and organizations have been mentioned in this report.

  1. Abnex 
  2. Access Clinical Research
  3. Accurate Clinical Research
  4. Acurian 
  5. Advanced Clinical
  6. AD VERBUM
  7. Affordable Clinical Trials Outsourcing
  8. Akcelis
  9. Alleco Trials 
  10. Alliance for Clinical Research Excellence and Safety
  11. Allscripts
  12. American Liver Foundation
  13. American Society of Clinical Oncology
  14. Amgen
  15. Antidote
  16. ApotheCom
  17. Apparelyzed
  18. Apptomics
  19. AQLANE Medical
  20. Arden and Schmidt
  21. AstraZeneca
  22. ATLAS Medical Services
  23. AutoCruitment
  24. AXELLE Group
  25. Axiom Marketing
  26. BBK Worldwide
  27. BDD
  28. BIAPharm 
  29. Bioclinica
  30. Bio-Optronics
  31. BioScript
  32. Bladder & Bowel Community
  33. Blueprint Clinical 
  34. BlueTheory Clinical Trials
  35. BMC Group
  36. Box
  37. Bridge Clinical Research
  38. Bright Pharmaceutical Services
  39. Buzzreach 
  40. CaringKind
  41. C&C Clinical Laboratory Consulting
  42. Canadian Institute for Medical Advancement 
  43. Capsule Communications
  44. CarthagoPharma
  45. Center Point Clinical Services
  46. Centricity Health
  47. Chandler Chicco Agency
  48. Chase Medical Research
  49. Cinven
  50. Circuit Clinical
  51. Clariness 
  52. Clear Clinica
  53. Clinart MENA
  54. ClinEdge 
  55. Clinical Ambassador
  56. Clinical List America
  57. Clinical Trial
  58. Clinical Trial Connect
  59. Clinical Trials Group
  60. Clinical Trial Marketing Communications 
  61. Clinical Trial Networking 
  62. Clinical Trials Center
  63. ClinicalConnection
  64. Clinically Media
  65. ClinIntel
  66. Clinerion
  67. CliniSpan Health
  68. Clinspire Research
  69. Clintec
  70. Clintract 
  71. Clinverse 
  72. CMX Research
  73. Compass Research
  74. Continuum Clinical 
  75. CPS Research
  76. CROee
  77. CSSi
  78. CTM
  79. Cyclone
  80. Cytespace
  81. DAC Patient Recruitment Services
  82. DAVA Oncology
  83. DrFirst
  84. Eastern Medical
  85. Effectus CTR
  86. EGeen
  87. Elligo Health Research
  88. EmergingMed
  89. eNre
  90. ePatientFinder 
  91. eStudySite
  92. Euclid SR Partners
  93. European Organization for Research and Treatment of Cancer 
  94. EVERSANA
  95. FDAMap
  96. Fidelis Research
  97. Flatiron Health
  98. Foundation for the National Institutes of Health
  99. Foundation Medicine
  100. Friends of Cancer Research
  101. Gaea Clinical
  102. Galen Patient Recruitment
  103. GCP Clinical Studies
  104. Genentech
  105. Gitzo Pharmaceuticals 
  106. Global Clinical Trials
  107. Global Perspectives
  108. GuideStar Research
  109. Heron Therapeutics
  110. Ignite Data
  111. IMS Health
  112. Incontinence UK
  113. Innovative Trials
  114. INSPIRE
  115. Institute of Clinical Research India 
  116. Integrated Clinical Trial Services 
  117. IQVIA
  118. IRM
  119. JLL Partners
  120. JP Morgan Partners
  121. J Trotter Research & Consulting 
  122. KCR
  123. Klick Health
  124. Langland
  125. LeadSlinger
  126. Link2Trials
  127. Linical Accelovance 
  128. Live Doctors
  129. LongTaal
  130. Lyft
  131. Lymphoma Action
  132. Melanoma Research Alliance
  133. Medical Research South
  134. MediciGroup
  135. Merck Capital Ventures
  136. Miami Research Associates
  137. MMG
  138. Mondosano
  139. Mundipharma Research
  140. National Cancer Institute
  141. Northumbria Healthcare NHS Foundation Trust 
  142. nRollmed
  143. O4 Research
  144. One Research
  145. orphan reach
  146. Orphanos
  147. Osaka International Cancer Institute
  148. Pacific Grove 
  149. Parallel 6
  150. PAREXEL
  151. Patient Enrollment Advisors 
  152. Patient RM
  153. PatientEvolution
  154. Patients Direct
  155. PatientWise
  156. Patiro
  157. Pepgra
  158. Pfizer
  159. PharmaCentra
  160. Pharmaceutical Product Development 
  161. Pharm-Olam 
  162. phaware global association
  163. Physicians Plasma Alliance 
  164. Polaris Biopharma Consulting
  165. PPH plus
  166. Practice Fusion
  167. Praxis Communications 
  168. PRC Clinical
  169. Profil
  170. ProQuest Investments
  171. Publicis Healthcare Communications Group 
  172. PWNHealth
  173. QPS
  174. Radiant Research
  175. RealTime Software Solutions
  176. RemediumOne 
  177. Remedy Health Media
  178. Rep Network
  179. RESolutions
  180. S4 Research
  181. Seeker Health 
  182. Sinque Labs
  183. SitePartner
  184. SMO Clinical Research 
  185. SMO ClinPlus
  186. Society for Clinical Research Sites
  187. Spectrum Clinical Research
  188. Spinal Cord Injury Network
  189. Splash Clinical 
  190. SubjectWell
  191. SWOG Cancer Research
  192. Syneos Health
  193. Synexus
  194. TFS
  195. The Academic Network
  196. The Patient Experience Project 
  197. The Patient Recruiting Agency
  198. The Patient Recruitment Consultancy
  199. ThreeWire
  200. Topstone Research
  201. Total Clinical Trial Management
  202. Trial Connections
  203. Trialfacts
  204. TrialJoin
  205. TrialSpark
  206. TrialWire 
  207. Tudor Reilly Health
  208. Roche
  209. United BioSource 
  210. University of Exeter
  211. University of Glasgow
  212. University of Strathclyde
  213. Veristat
  214. Viomedo
  215. VisibilityRx 
  216. Vizae Clinical Trial Management
  217. WCCT Global
  218. WIRB-Copernicus Group
  219. Worldwide Clinical Trials
  220. X Factor Advertising

Request Customization

Please select a suitable option for customization in the report

PRICING DETAILS

USD 4,499

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site / office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm / enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com